semaglutide court case update Ozempic copies restricted after US judge denies injunction Novo Nordisk ends legal proceedings
Description
Dysgeusia also has been reported by people taking an oral form of semaglutide
N Engl J Med 373:22472257 Marso SP, Daniels GH, Brown-Frandsen K et al (2016) Liraglutide and cardiovascular outcomes in type 2 diabetes
Methods This systematic review and meta-analysis, registered in PROSPERO and conducted per PRISMA guidelines, assessed the effects of GLP-1RA use on AUD and alcohol-related outcomes in adults with obesity or type 2 diabetes mellitus
Pros: Clinically proven to result in 510% weight loss
Most are mild to moderate and tend to improve as your body adjusts, especially during the dose escalation period
